 Home > Medical News > Latest Medical News > Poinsettia: Omeprazole Sodium for Injection passed the consistency evaluation

Poinsettia: Omeprazole Sodium for Injection passed the consistency evaluation

 Last Update: 2021-06-11
 Source: Internet
 Author: User

Tags

renin inhibitor drugs

stem cells used

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On May 26, Poinsettia announced that its wholly-owned subsidiary Guangzhou Poinsettia Pharmaceuticals recently received a notice issued by the State Food and Drug Administration.

Mainly used for: ① bleeding from peptic ulcer, bleeding from anastomotic ulcer; ② acute gastric mucosal damage in an emergency state, acute gastric mucosal damage caused by non-steroidal anti-inflammatory drugs; ③ prevention of severe diseases (such as cerebral hemorrhage, severe Trauma, etc.

Omeprazole is the first proton pump inhibitor on the market, which inhibits gastric acid secretion by inhibiting the H+-K+-ATPase activity of gastric parietal cells.

According to data from Menet.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.